Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine and Molecular Imaging|March 28, 2025
Beyond similarities: overall survival and prognostic insights from [¹⁷⁷Lu]Lu-DOTATOC therapy in neuroendocrine tumorsTristan Ruhwedel, Julian Rogasch, Imke Schatka, et al.
Cancers|April 12, 2022
Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [<sup>177</sup>Lu]Lu-DOTATOCMarkus Galler, Julian M M Rogasch, Kai Huang, et al.
Clinical Nuclear Medicine|October 10, 2024
To Perform, or Not to Perform Interim PET: Questioning the Impact of Midtherapy Evaluation During PRRT in GEP-NET PatientsChristoph Wetz, Tristan Ruhwedel, Julian M M Rogasch, et al.
Visceral Medicine|February 29, 2020
Influence of Gender on Therapy and Outcome of Neuroendocrine Tumors of Gastroenteropancreatic Origin: A Single-Center AnalysisMartina T Mogl, Eva M Dobrindt, Josephine Buschermöhle, et al.
Cancers|October 23, 2021
Added Value of Tomoelastography for Characterization of Pancreatic Neuroendocrine Tumor Aggressiveness Based on StiffnessEmin Gültekin, Christoph Wetz, Jürgen Braun, et al.
Cancers|February 10, 2021
The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [<sup>177</sup>Lu]Lu-DOTATOC-PRRT: A Retrospective AnalysisTristan Ruhwedel, Julian M M Rogasch, Kai Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Pre-operative quantification of pulmonary function using hybrid-SPECT/low-dose-CT: A pilot studyPhilipp Genseke, Christoph Wetz, Thekla Wallbaum, et al.
Diagnostics (Basel, Switzerland)|September 25, 2020
Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?Christoph Wetz, Julian Rogasch, Philipp Genseke, et al.
Clinical Nuclear Medicine|April 25, 2024
Keeping Up With ChatGPT: Evaluating Its Recognition and Interpretation of Nuclear Medicine ImagesJulian M M Rogasch, Hans V Jochens, Giulia Metzger, et al.
International Journal of Molecular Sciences|June 26, 2019
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and FutureAnna Kathrin Stueven, Antonin Kayser, Christoph Wetz, et al.
Pageof 3